CD163 and non-small cell lung carcinoma: Markers of inflammatory macrophages, major histocompatibility complex (MHC) class II co-stimulatory molecules (CD40, CD80, and CD86), and markers of anti-inflammatory macrophages (CD163 and CD206) have been detected in TAMs in early-stage NSCLC (21).